Vaxart, Inc. Proceeds from Maturities, Prepayments and Calls of Long-term Investments
Vaxart, Inc. (VXRT) reported Proceeds from Maturities, Prepayments and Calls of Long-term Investments of $1.00 million for the 3-month period ending 2015-09-30, per its 10-Q filed 2015-11-06.
Discontinued › Cash Flow › Investing Activities
us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfLongtermInvestments · last filed 2016-09-13
- Vaxart, Inc. proceeds from maturities, prepayments and calls of long-term investments for the quarter ending 2015-09-30 was $1.00M.
- Vaxart, Inc. proceeds from maturities, prepayments and calls of long-term investments for the quarter ending 2015-06-30 was $0.00.
- Vaxart, Inc. proceeds from maturities, prepayments and calls of long-term investments for the quarter ending 2015-03-31 was $0.00.
- Vaxart, Inc. proceeds from maturities, prepayments and calls of long-term investments for fiscal 2015 was $6.90M.
| Period end | Proceeds from Maturities, Prepayments and Calls of Long-term Investments 3 month | Proceeds from Maturities, Prepayments and Calls of Long-term Investments 6 month | Proceeds from Maturities, Prepayments and Calls of Long-term Investments 9 month | Proceeds from Maturities, Prepayments and Calls of Long-term Investments 12 month |
|---|---|---|---|---|
| 2015-09-30 | $1.00M 10-Q · filed 2015-11-06 | $1.00M derived: sum of 2 quarters · filed 2016-09-13 | $1.00M derived: sum of 3 quarters · filed 2016-09-13 | |
| 2015-06-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2016-09-13 | $0.00 derived: sum of 2 quarters · filed 2016-09-13 | $6.90M 10-K · filed 2016-09-13 | |
| 2015-03-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2016-05-10 | $6.90M 10-Q · filed 2016-05-10 | ||
| 2014-12-31 | $6.90M 10-Q · filed 2016-02-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kalaris Therapeutics, Inc. (KLRS) | United States | $0.073B | -2.19 |
| Atara Biotherapeutics, Inc. (ATRA) | United States | $0.086B | -6.48 |
| Pelthos Therapeutics Inc. (PTHS) | United States | $0.086B | -1.20 |
| CHAMPIONS ONCOLOGY, INC. (CSBR) | United States | $0.070B | -68.02 |
| COGNITION THERAPEUTICS INC (CGTX) | United States | $0.090B | -6.52 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B | |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| Cardiff Oncology, Inc. (CRDF) | United States | $0.101B | -2.22 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B |